Sucheth Davuluri, Vice-Chairman and Chief Executive Officer, said, "The record high revenue this quarter, driven by CMS commercial projects, led to the operating leverage reflected in the EBITDA margins, and we expect this momentum to continue through the rest of the year.

Also Read: Neuland Laboratories shares tank 11% despite FY26 growth assurance, Goldman optimism

Given the investments we are making, Neuland is well-positioned to take advantage of the number of growth opportunities available to us in both the CDMO as well as the generic APIs space.”

Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Laboratories, said, "Customer interest in Neuland’s capabilities continues to be on the rise as we see increased engagement with a diverse range of customers.

Our reputation

See Full Page